The first ones to get the vaccine are the front-line workers estimated at 30 million. The second group to follow are people above the age of 50 and those below the age of 50 with co-morbidity. The second group is estimated at 270 million. I am sure the AADHAR project will be of immense use.
Read more at:
Read more at:
It is noteworthy that an Indian Pharmaceutical (Bharat Biotech)
company could develop a vaccine in record time to address the emergency.
No comments:
Post a Comment